Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using ...

The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...

Lungs Double lung transplantation appears to offer superior survival outcomes to single lung transplantation in patients with interstitial pulmonary fibrosis who are younger than 70 years. Individuals ...

Quantitative CT metrics can be used to define progressive pulmonary fibrosis and have prognostic value in patients with ...

New-onset interstitial lung disease can be detected up to 10 years after initial negative screening in patients with systemic sclerosis, with a higher mortality risk vs those without lung involvement.

Highlights in interstitial lung disease (ILD) from the American College of Chest Physicians (CHEST) 2023 annual meeting include findings in antifibrotic therapy, use of artificial intelligence in ILD ...

Brainomix E-Lung AI Imaging Technology Selected As Co-Primary Endpoint In Boehringer Ingelheim Phase 3 Clinical Trial In Pulmonary Fibrosis. <li /> The DROP-FPF trial is the first Phase 3 trial in ...

Researchers at the University of Exeter and clinical radiopharmaceutical company Serac Healthcare Ltd are researching a new molecular imaging marker which could help to detect disease progression ...

SELLERSVILLE, Pennsylvania (WPVI) -- A nagging cough or congestion might not mean much to most of us. But it can be serious for those with lung conditions. Exercise testing can help specialists find ...